{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_6348", "batch_size": 200, "batch_pos": 170, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "'manufacture' is a neutral verb.", "method": "llm_batch", "batch_id": "batch_2_5528", "batch_size": 200, "batch_pos": 130, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses future manufacturing uncertainty, lacking moderate verbs and scale/impact.", "method": "llm_batch", "batch_id": "batch_3_19308", "batch_size": 200, "batch_pos": 80, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_17164", "batch_size": 200, "batch_pos": 66, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports uncertainty about manufacturing capacity, lacking explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_18596", "batch_size": 200, "batch_pos": 59, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment describes uncertainty about manufacturing quantity but does not use a minimiser with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_17472", "batch_size": 200, "batch_pos": 20, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment describes uncertainty about numbers, not a bare negation.", "method": "llm_batch", "batch_id": "batch_7_3220", "batch_size": 200, "batch_pos": 13, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes a current state of uncertainty about a capability: 'It is too early to tell how many doses Moderna will be able to manufacture'.", "method": "llm_batch", "batch_id": "batch_8_4648", "batch_size": 200, "batch_pos": 92, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
